NMTRC014: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: Between 1 Year(s) - 31 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Confirmed diagnosis of neuroblastoma. 2. All patients must be in complete remission (CR). 3. No evidence of residual disease by CT/MRI and IBG scan.

You may not be eligible for this study if the following are true:

  • 1. Subjects who are currently receiving another investigation l drug are excluded from participation. 2. Subjects who are currently receiving other anticancer agents are not eligible. 3. Subjects who have an uncontrolled infection are not eligible.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.